These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 28295199

  • 1. Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme.
    Scott S, Travis D, Whitby L, Bainbridge J, Cross NCP, Barnett D.
    Br J Haematol; 2017 May; 177(3):414-422. PubMed ID: 28295199
    [Abstract] [Full Text] [Related]

  • 2. External quality assessment of p210 BCR-ABL1 transcript quantification by RT-qPCR: Findings and recommendations.
    Fu Y, Zhang R, Wu Q, Zhang J, Bao L, Li J.
    Int J Lab Hematol; 2019 Feb; 41(1):46-54. PubMed ID: 30203581
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Kottwitz D, El Hadi H, El Amrani M, Cabezas S, Dehbi H, Nadifi S, Quessar A, Colomer D, Moumen A, Sefrioui EL.
    Int J Hematol; 2015 Sep; 102(3):335-41. PubMed ID: 26243622
    [Abstract] [Full Text] [Related]

  • 4. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
    Ruiz MS, Sánchez MB, Vera Contreras YM, Agrielo E, Alonso M, Altuna ME, Anchordoqui MS, Asinari M, Bonetto ME, Camargo M, Giere I, González J, Granda Alacote AC, Guerra J, Gutiérrez M, Maldonado C, Makiya R, Manrique G, Monaco ME, Rozo JC, Santamaría C, Seravalle A, Zea O, Zubillaga MN, Mordoh J, Larripa I, Bianchini M.
    Clin Chem Lab Med; 2020 Nov 26; 58(12):2025-2035. PubMed ID: 32374276
    [Abstract] [Full Text] [Related]

  • 5. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M, Whale AS, Akiki S, Piechocki K, Torrado C, Myint T, Cowen S, Griffiths M, Reid AG, Apperley J, White H, Huggett JF, Foroni L.
    Clin Chem; 2017 Feb 26; 63(2):525-531. PubMed ID: 27979961
    [Abstract] [Full Text] [Related]

  • 6. Real-time quantification assay to monitor BCR-ABL1 transcripts in chronic myeloid leukemia.
    Foskett P, Gerrard G, Foroni L.
    Methods Mol Biol; 2014 Feb 26; 1160():115-24. PubMed ID: 24740226
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR].
    Larripa I, Ruiz MS, Gutiérrez M, Bianchini M.
    Medicina (B Aires); 2017 Feb 26; 77(1):61-72. PubMed ID: 28140313
    [Abstract] [Full Text] [Related]

  • 9. Comparison of molecular responses based on BCR-ABL1% (IS) results from an in-house TaqMan-based qPCR versus Xpert(®) assay in CML patients on tyrosine kinase inhibitor therapy.
    Boeckx N, Laer CV, Roover JD, Wilmsen B, Bruyninckx K, Pauwels S.
    Acta Clin Belg; 2015 Aug 26; 70(4):237-43. PubMed ID: 26166681
    [Abstract] [Full Text] [Related]

  • 10. BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia.
    Lee SE, Choi SY, Kim SH, Song HY, Yoo HL, Lee MY, Kang KH, Hwang HJ, Jang EJ, Kim DW.
    Korean J Intern Med; 2017 Jan 26; 32(1):125-136. PubMed ID: 27334764
    [Abstract] [Full Text] [Related]

  • 11. Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.
    Furuya D, Moriai M, Koizumi Y, Endo T, Asanuma K, Yanagihara N, Takahashi S.
    Int J Clin Oncol; 2019 Jul 26; 24(7):871-875. PubMed ID: 30798394
    [Abstract] [Full Text] [Related]

  • 12. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
    Koren-Michowitz M, Shimoni A, Daraio F, Crasto F, Lorenzatti R, Volchek Y, Amariglio N, Gottardi E, Saglio G, Nagler A.
    Biol Blood Marrow Transplant; 2015 Oct 26; 21(10):1852-5. PubMed ID: 26151304
    [Abstract] [Full Text] [Related]

  • 13. Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients.
    Arun AK, Senthamizhselvi A, Mani S, Vinodhini K, Janet NB, Lakshmi KM, Abraham A, George B, Srivastava A, Srivastava VM, Mathews V, Balasubramanian P.
    Int J Lab Hematol; 2017 Jun 26; 39(3):235-242. PubMed ID: 28035733
    [Abstract] [Full Text] [Related]

  • 14. Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
    Iriyama N, Fujisawa S, Yoshida C, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Inokuchi K, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H.
    Am J Hematol; 2015 Apr 26; 90(4):282-7. PubMed ID: 25530131
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
    Foroni L, Wilson G, Gerrard G, Mason J, Grimwade D, White HE, de Castro DG, Austin S, Awan A, Burt E, Clench T, Farruggia J, Hancock J, Irvine AE, Kizilors A, Langabeer S, Milner BJ, Nickless G, Schuh A, Sproul A, Wang L, Wickham C, Cross NC.
    Br J Haematol; 2011 Apr 26; 153(2):179-90. PubMed ID: 21382019
    [Abstract] [Full Text] [Related]

  • 17. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
    Griffiths M, Patton SJ, Grossi A, Clark J, Paz MF, Labourier E, Labceutics International BCR-ABL1 Standardization Study Group.
    Arch Pathol Lab Med; 2015 Apr 26; 139(4):522-9. PubMed ID: 25061833
    [Abstract] [Full Text] [Related]

  • 18. Cell sorting enables interphase fluorescence in situ hybridization detection of low BCR-ABL1 producing stem cells in chronic myeloid leukaemia patients beyond deep molecular remission.
    van Kooten Niekerk PB, Petersen CC, Nyvold CG, Ommen HB, Roug AS, Nederby L, Hokland P, Kjeldsen E.
    Br J Haematol; 2014 Jan 26; 164(1):53-60. PubMed ID: 24903628
    [Abstract] [Full Text] [Related]

  • 19. A novel approach for BCR-ABL1 standardization to improve International Scale estimation.
    Maes B, Bakkus M, Boeckx N, Boone E, Cauwelier B, Denys B, De Schouwer P, Devos T, El Housni H, Hillen F, Jacobs K, Lambert F, Louagie H, Maes MB, Meeus P, Moreau E, Nollet F, Peeters K, Saussoy P, Van Lint P, Vaerman JL, Vaeyens F, Vandepoele K, Vannuffel P, Ver Elst K, Vermeulen K, Bruyndonckx R, Belgian working group on BCR-ABL1 IS standardization.
    Int J Lab Hematol; 2016 Dec 26; 38(6):674-684. PubMed ID: 27460189
    [Abstract] [Full Text] [Related]

  • 20. Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA.
    Bartley PA, Ross DM, Latham S, Martin-Harris MH, Budgen B, Wilczek V, Branford S, Hughes TP, Morley AA.
    Int J Lab Hematol; 2010 Dec 26; 32(6 Pt 1):e222-8. PubMed ID: 20491997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.